|
Study participants and institutions. |
|||||
| Institution (Consortium) |
Participants |
Participated in: |
|||
|
|
|||||
| Exp. 1 (fixed activated blood) |
Exp. 2 (shipped whole blood) |
Exp. 3 (cryo-preserved PBMC) |
Exp. 4 (cryo-preserved PBMC with lyoplates) |
||
|
|
|||||
| University of Montreal (CANVAC) |
Rafick Sekaly, Eva Roig, Claire Landry |
x |
x |
x |
|
| Chelsea and Westminster Hospital (IAVI) |
Jill Gilmour, Peter Hayes |
x |
x |
x |
|
| Uganda Virus Research Institute (IAVI) |
Josephine Birungi, Omu Anzala |
x |
|||
| Centre Hospitalier Universitaire Vaudois (EUROVAC) |
Giuseppe Pantaleo, Alexandre Harari, Miguel Garcia |
x |
x |
x |
|
| Fred Hutchison Cancer Research Center (HVTN) |
Helen Horton ,Ruth Baydo, Ian Frank |
x |
x |
x |
x |
| Duke University (HVTN) |
Kent Weinhold, Janet Ottinger, Megan Baker, Jennifer Holbrook |
x |
x |
x |
|
| Vaccine Research Center, NIH |
Mario Roederer, Richard Koup, Laurie Lamoreaux |
x |
x |
x |
x |
| Merck and Co. |
Timothy Tobery, Lynda Tussey, Kara Punt |
x |
x |
x |
x |
| University of California, San Francisco |
Barry Bredt, Elizabeth Sinclair, Lorrie Epling |
x |
x |
x |
|
| BD Biosciences |
Vernon Maino, Holden Maecker, Maria Suni |
x |
x |
x |
x |
| Sanofi Pasteur |
Nolwenn Nougarede, Sophia El-Bahi |
x |
|||
| National Inst. Communicable Diseases, South Africa |
Clive Gray, Hazel Maila |
x |
|||
| Massachusetts General Hospital |
Marcus Altfeld, Gailet Alter |
x |
|||
| University of Pennsylvania |
Jean Boyer, Sandra Calarota |
x |
|||
| Henry Jackson Foundation |
Josephine Cox, Ellen Kuta |
x |
|||
|
Financial and Operational Support: Aline Rinfret, CANVAC; Patricia D'Souza, NIAID, NIH; Janice Darden, NIAID, NIH | |||||
Maecker et al. BMC Immunology 2005 6:13 doi:10.1186/1471-2172-6-13 |
|||||